Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? Comment

被引：0

作者：

Grogger, J ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Publ Policy, Los Angeles, CA 90024 USA

来源：

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION | 2001年 / 96卷 / 456期

关键词：

D O I：

暂无

中图分类号：

O21 [概率论与数理统计]; C8 [统计学];

学科分类号：

020208 ; 070103 ; 0714 ;

摘要：

引用

页码：1268 / 1269

页数：2

共 29 条

[21] Comment on: Should we really worry about “launch delays” of new drugs in OECD countries? by L. Garatinni and S. Ghislandi
Joshua Cohen
The European Journal of Health Economics, 2007, 8 : 169 - 170
[22] Comment on: Should we really worry about "launch delays" of new drugs in OECD countries? by L. Garatinni and S. Ghislandi
Cohen, Joshua
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (02): : 169 - 170
[23] Comment: Systematic Review and Meta-Analysis of Efficacy, Safety, and Tolerability Data from Randomized Controlled Thais of Drugs Used to Treat Postherpetic Neuralgia
Nalamachu, Srinivas
ANNALS OF PHARMACOTHERAPY, 2012, 46 (05) : 764 - +
[24] Executive summary of the National Research Council's report 'Informing America's policy on illegal drugs: what we don't know keeps hurting us' - Commentaries - The best should not be the enemy of the good
Kleber, HD
ADDICTION, 2002, 97 (06) : 660 - 661
[25] Comment: Systematic Review and Meta-Analysis of Efficacy, Safety, and Tolerability Data from Randomized Controlled Thais of Drugs Used to Treat Postherpetic Neuralgia REPLY
Edelsberg, John S.
Lord, Claudia
Oster, Gerry
ANNALS OF PHARMACOTHERAPY, 2012, 46 (05) : 765 - 765
[26] Executive summary of the National Research Council's report 'Informing America's policy on illegal drugs: what we don't know keeps hurting us' - Commentaries - A report that should become a well-thumbed desk companion
Bammer, G
ADDICTION, 2002, 97 (06) : 659 - 660
[27] REVIEW OF REAL-WORLD DATA USE IN FRENCH ECONOMIC AND PUBLIC HEALTH ASSESSMENT COMMITTEE'S (CEESP) EFFICIENCY OPINIONS FOR ANTICANCER DRUGS
Tchouen, N.
Chartier, M.
Gaudin, A. F.
Cotte, F. E.
VALUE IN HEALTH, 2022, 25 (01) : S181 - S181
[28] VARIATION OF DATA SOURCE USED FOR BASELINE POPULATION AND FOR NATURAL COURSE OF ALZHEIMER'S DISEASE PROGRESSION IN MODEL-BASED ECONOMIC EVALUATION OF TREATMENT OF AD
Lerjanyakun, V
Kunisawa, S.
Imanaka, Y.
VALUE IN HEALTH, 2016, 19 (07) : A853 - A853
[29] Reply to Henriksen, S.; Rinaldo, CH Should SVGp12 Be Used for JC Polyomavirus Studies? Comment on "Prezioso et al. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains. Viruses 2022, 14, 2070"
Prezioso, Carla
Moens, Ugo
Pietropaolo, Valeria
VIRUSES-BASEL, 2023, 15 (01):

← 1 2 3 →